Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 28, 2007 16:01 ET | Source: Pharmos Corporation

Pharmos Receives Notice Related to Nasdaq Minimum Bid Price Rule

ISELIN, N.J., Sept. 28, 2007 (PRIME NEWSWIRE) -- Pharmos Corporation (Nasdaq:PARS) today announced that it received notice on September 26, 2007 from The Nasdaq Stock Market that the minimum bid price...
June 20, 2007 08:30 ET | Source: Pharmos Corporation

Pharmos Commences Phase 2b Irritable Bowel Syndrome Study

ISELIN, N.J., June 20, 2007 (PRIME NEWSWIRE) -- Pharmos Corporation (Nasdaq:PARS) announced today patient screening has commenced in its Phase 2b clinical trial of dextofisopam, which is expected to...